Sage Journals: Discover world-class research

Abstract

Background

Histamine and leukotriene are released after being triggered by allergen exposure. The combination of leukotriene receptor antagonist (LTRA) and H1-antihistamine (AH) is utilized to control the allergic rhinitis (AR) symptoms after the failure of either AH or LTRA.

Objective

This study aimed to investigate the effects of the combination of H1-antihistamine and leukotriene receptor antagonist (AH-LTRA) in patients with AR.

Methods

Randomized controlled trials studying the effects of AH-LTRA versus AH alone on rhinoconjuncitivits symptoms in patients with AR were included. Data were pooled for meta-analysis. The outcomes were nasal symptoms, ocular symptoms, disease-specific quality of life, and adverse events. Meta-analyses were performed to compare the outcomes between AH-LTRA and AH. Subgroup analyses by AR subtype, asthma, and pediatric patients were performed.

Results

Fourteen studies (3271 participants) met the inclusion criteria. The results favored the effects of AH-LTRA on (1) composite nasal symptom score (standardized mean difference [SMD]: −0.20; 95% confidence interval [CI]: −0.36, −0.03), (2) rhinorrhea (SMD: −0.14; 95% CI: −0.27, −0.02), and (3) sneezing (SMD: −0.15; 95% CI: −0.27, −0.02). Subgroup analyses revealed that results favored the effects of AH-LTRA for perennial AR (SMD: −0.57; 95% CI: −0.87, −0.26) but not in the seasonal AR subgroup (SMD: −0.09; 95% CI: −0.21, 0.04), P = .004. There were no differences between AH-LTRA and AH on nasal obstruction, itching, ocular symptoms, Rhinoconjunctivitis Quality of life Questionnaire and adverse events. Due to limited number of included studies, effects on asthma and pediatric subgroups could not be assessed.

Conclusion

For controlling rhinoconjunctivitis symptoms in patients with AR, AH-LTRA provided greater beneficial effects on composite nasal symptoms, rhinorrhea, and sneezing compared to AH alone. These effects were shown in patients with perennial AR.

Keywords

antihistamine leukotriene receptor antagonist allergic rhinitis asthma histamine leukotriene nasal obstruction sneezing itching seasonal

Get full access to this article

View all access options for this article.

References

Nathan

RA.

Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.

Ann Allergy Asthma Immunol. 2003; 90:182–190; quiz 90–91, 232.

Borriello

Iannone

Marone

Histamine release from mast cells and basophils.

Handb Exp Pharmacol. 2017; 241:121–139.

Lipworth

BJ.

Leukotriene-receptor antagonists.

Lancet. 1999; 353:57–62.

Bisgaard

Olsson

Bende

Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans.

Clin Allergy. 1986; 16:289–297.

Okuda

Watase

Mezawa

Liu

CM.

The role of leukotriene D4 in allergic rhinitis.

Ann Allergy. 1988; 60:537–540.

Bousquet

Khaltaev

Cruz

, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63 Suppl 86:8–160.

Seidman

Gurgel

Lin

, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015; 152:S1–S43.

Moher

Liberati

Tetzlaff

Altman

; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6:e1000097.

Higgins

JPT

Green

Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. www.cochrane-handbook.org.

10.

Review Manager (RevMan) [Computer program]. Version 5.1.6 ed. Copenhagen, Denmark: The Nordic Cochrane Centre. The Cochrane Collaboration; 2011.

11.

Ciebiada

Gorska-Ciebiada

DuBuske

Gorski

Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.

Ann Allergy Asthma Immunol. 2006; 97:664–671.

12.

Malice

Dass

Reiss

TF.

Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.

J Asthma. 2009; 46:878–883.

13.

Ciebiada

Barylski

Gorska Ciebiada

Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.

Am J Rhinol Allergy. 2013; 27:e58–e62.

14.

Ciebiada

Kmiecik

DuBuske

Gorski

Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. J Investig Allergol Clin Immunol. 2008; 18:343–349.

15.

Ciebiada

Gorska-Ciebiada

Barylski

Kmiecik

Gorski

Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.

Am J Rhinol Allergy. 2011; 25:e1–e6.

16.

Cingi

Gunhan

Gage-White

Unlu

Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.

Laryngoscope. 2010; 120:1718–1723.

17.

Erdogan

Sanli

Paksoy

Altin

Aydin

Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination.

Kulak Burun Bogaz Ihtis Derg. 2014; 24:217–224.

18.

Gupta

Matreja

Efficacy of montelukast and levocetirizine as treatment for allergic rhinitis. J Aller Ther. 2010; 1:103.

19.

Kurowski

Kuna

Gorski

Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.

Allergy. 2004; 59:280–288.

20.

Abdullah

Tsen

, et al. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis—a randomized placebo-controlled study. Pediatr Pulmonol. 2009; 44:1085–1092.

21.

Meltzer

Malmstrom

, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000; 105:917–922.

22.

Nayak

Philip

Malice

Reiss

; Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol. 2002; 88:592–600.

23.

Watanasomsiri

Poachanukoon

Vichyanond

Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children.

Asian Pac J Allergy Immunol. 2008; 26:89–95.

24.

Wilson

Dempsey

Sims

Coutie

Paterson

Lipworth

BJ.

Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy. 2000; 30:833–838.

25.

Wilson

Orr

Coutie

Sims

Lipworth

BJ.

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.

Clin Exp Allergy. 2002; 32:126–132.

26.

Haberal

Corey

JP.

The role of leukotrienes in nasal allergy.

Otolaryngol Head Neck Surg. 2003; 129:274–279.

27.

Dempsey

OJ.

Leukotriene receptor antagonist therapy.

Postgrad Med J. 2000; 76:767–773.

28.

Roumestan

Henriquet

Gougat

, et al. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms. Clin Exp Allergy. 2008; 38:947–956.

29.

Hore

Georgalas

Scadding

Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis—a systematic review of randomized controlled trials.

Clin Exp Allergy. 2005; 35:207–212.

30.

Reinberg

Gervais

Levi

Smolensky

Del Cerro

Ugolini

Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods.

J Allergy Clin Immunol. 1988; 81:51–62.

31.

Aoyagi

Watanabe

Sekine

, et al. Circadian variation in nasal reactivity in children with allergic rhinitis: correlation with the activity of eosinophils and basophilic cells. Int Arch Allergy Immunol. 1999; 120 Suppl 1:95–99.

32.

Liu

Zhou

Chen

Liu

Oral antihistamines alone vs in combination with leukotriene receptor antagonists for allergic rhinitis: a meta-analysis.

Otolaryngol Head Neck Surg. 2018; 158:450–458.

33.

Wise

Lin

Toskala

, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018; 8:108–352.

Leukotriene Receptor Antagonist Addition to H1-Antihistamine Is Effective for Treating Allergic Rhinitis: A Systematic Review and Meta-analysis

Abstract

Background

Objective

Methods

Results

Conclusion

Keywords

Get full access to this article

References